Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Nutrients ; 13(2)2021 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-33572810

RESUMEN

Preclinical evidence suggests that n-3 fatty acids EPA and DHA (Omega-3) supplemented as phospholipids (PLs) may be more effective than triacylglycerols (TAGs) in reducing hepatic steatosis. To further test the ability of Omega-3 PLs to alleviate liver steatosis, we used a model of exacerbated non-alcoholic fatty liver disease based on high-fat feeding at thermoneutral temperature. Male C57BL/6N mice were fed for 24 weeks a lard-based diet given either alone (LHF) or supplemented with Omega-3 (30 mg/g diet) as PLs (krill oil; ω3PL) or TAGs (Epax 3000TG concentrate; ω3TG), which had a similar total content of EPA and DHA and their ratio. Substantial levels of TAG accumulation (~250 mg/g) but relatively low inflammation/fibrosis levels were achieved in the livers of control LHF mice. Liver steatosis was reduced by >40% in the ω3PL but not ω3TG group, and plasma ALT levels were markedly reduced (by 68%) in ω3PL mice as well. Krill oil administration also improved hepatic insulin sensitivity, and its effects were associated with high plasma adiponectin levels (150% of LHF mice) along with superior bioavailability of EPA, increased content of alkaloids stachydrine and trigonelline, suppression of lipogenic gene expression, and decreased diacylglycerol levels in the liver. This study reveals that in addition to Omega-3 PLs, other constituents of krill oil, such as alkaloids, may contribute to its strong antisteatotic effects in the liver.


Asunto(s)
Suplementos Dietéticos , Aceites de Pescado/farmacología , Enfermedad del Hígado Graso no Alcohólico/terapia , Obesidad/terapia , Fosfolípidos/farmacología , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Dieta Alta en Grasa/efectos adversos , Modelos Animales de Enfermedad , Euphausiacea , Vivienda para Animales , Resistencia a la Insulina , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/etiología , Obesidad/etiología
2.
Am J Hum Genet ; 99(2): 414-22, 2016 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-27426735

RESUMEN

tRNA synthetase deficiencies are a growing group of genetic diseases associated with tissue-specific, mostly neurological, phenotypes. In cattle, cytosolic isoleucyl-tRNA synthetase (IARS) missense mutations cause hereditary weak calf syndrome. Exome sequencing in three unrelated individuals with severe prenatal-onset growth retardation, intellectual disability, and muscular hypotonia revealed biallelic mutations in IARS. Studies in yeast confirmed the pathogenicity of identified mutations. Two of the individuals had infantile hepatopathy with fibrosis and steatosis, leading in one to liver failure in the course of infections. Zinc deficiency was present in all affected individuals and supplementation with zinc showed a beneficial effect on growth in one.


Asunto(s)
Alelos , Retardo del Crecimiento Fetal/genética , Discapacidad Intelectual/genética , Isoleucina-ARNt Ligasa/genética , Hepatopatías/congénito , Hepatopatías/genética , Hipotonía Muscular/congénito , Hipotonía Muscular/genética , Mutación , Adolescente , Animales , Niño , Preescolar , Suplementos Dietéticos , Hígado Graso/genética , Femenino , Fibrosis/genética , Humanos , Lactante , Recién Nacido , Isoleucina-ARNt Ligasa/deficiencia , Fallo Hepático/genética , Masculino , Síndrome , Pez Cebra/genética , Zinc/administración & dosificación , Zinc/deficiencia , Zinc/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA